This company has no active jobs
VALIDOGEN GmbH is a leading Austrian contract research and development company in the field of microbial protein expression. Based on its technology platform known as UNLOCK PICHIA®, VALIDOGEN develops industrial protein production strains and bioprocesses for the manufacture of biopharmaceuticals, enzymes and various other recombinant proteins. Founded in 2008, the company emerged to a globally recognized player in the field of Pichia pastoris based protein expression. VALIDOGEN is a private company and subsidiary of the KonValue Group.